Medirom Healthcare Closes JPY400M Convertible Bond Sale
Ticker: MRM · Form: 6-K · Filed: Dec 15, 2025 · CIK: 1819704
Sentiment: neutral
Topics: debt-financing, convertible-bonds, capital-raise
TL;DR
Medirom Healthcare just sold JPY400M in convertible bonds to 11 investors on Dec 12, 2025.
AI Summary
On December 12, 2025, Medirom Healthcare Technologies Inc. completed the sale and issuance of JPY400,000,000 in unsecured convertible bonds with share options to 11 investors. These bonds are referred to as the "Third Unsecured Convertible-Type Corporate Bonds with Share Options."
Why It Matters
This transaction provides Medirom Healthcare with additional capital, potentially for expansion or operational needs, through the issuance of convertible debt.
Risk Assessment
Risk Level: medium — The issuance of convertible bonds can dilute existing shareholder value if converted, and the company's financial health will determine its ability to repay the principal.
Key Numbers
- JPY400.0M — Convertible Bonds Issued (Represents capital raised by Medirom Healthcare)
Key Players & Entities
- Medirom Healthcare Technologies Inc. (company) — Issuer of the bonds
- JPY400,000,000 (dollar_amount) — Aggregate principal amount of bonds issued
- December 12, 2025 (date) — Closing date of the bond sale
- 11 investors (person) — Purchasers of the bonds
FAQ
What is the principal amount of the convertible bonds issued?
The aggregate principal amount of the bonds issued is JPY400,000,000.
When did Medirom Healthcare close the sale of these bonds?
The Company closed the sale and issuance on December 12, 2025.
How many investors purchased the bonds?
The bonds were sold to 11 investors.
What type of bonds were issued?
The bonds issued were the Third Unsecured Convertible-Type Corporate Bonds with Share Options.
What is the principal executive office address of Medirom Healthcare Technologies Inc.?
The principal executive office is located at 2-3-1 Daiba, Minato-ku, Tokyo, Japan.
Filing Stats: 991 words · 4 min read · ~3 pages · Grade level 17.9 · Accepted 2025-12-15 06:05:00
Filing Documents
- tm2533294d2_6k.htm (6-K) — 17KB
- 0001104659-25-120786.txt ( ) — 18KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MEDIROM H EALTHCARE TECHNOLOGIES INC. Date: December 15, 2025 By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara Title: Chief Financial Officer